Ekopak NV (EBR:EKOP)
Belgium · Delayed Price · Currency is EUR 3.550
-0.055 (-1.53%)
Sep 18, 2026, 5:38 PM CET
Ekopak NV Revenue
Ekopak NV had revenue of 24.01M EUR in the half year ending June 30, 2026, a decrease of -26.73%. This brings the company's revenue in the last twelve months to 53.99M, up 37.68% year-over-year. In the year 2025, Ekopak NV had annual revenue of 53.71M with 11.32% growth.
Revenue (ttm)
53.99M
Revenue Growth
+37.68%
P/S Ratio
1.17
Revenue / Employee
199.92K
Employees
265
Market Cap
62.14M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.71M | 5.46M | 11.32% |
| Dec 31, 2024 | 48.25M | 10.69M | 28.45% |
| Dec 31, 2023 | 37.56M | 18.72M | 99.33% |
| Dec 31, 2022 | 18.85M | 7.28M | 63.00% |
| Dec 31, 2021 | 11.56M | 1.78M | 18.20% |
| Dec 31, 2020 | 9.78M | -558.00K | -5.40% |
| Dec 31, 2019 | 10.34M | 3.58M | 52.99% |
| Dec 31, 2018 | 6.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Agfa-Gevaert NV | 1.08B |
| Miko NV | 312.23M |
| Atenor | 132.98M |
| ABO-Group Environment NV | 107.42M |
| Banqup Group | 53.10M |
| Flowsparks NV | 10.17M |
| Hyloris Pharmaceuticals | 7.94M |
| Banimmo | 7.52M |